Pillstats
Rx only · Tablet · Sublingual

Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate

Buprenorphine Hydrochloride + Naloxone Hydrochloride Dihydrate

11 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US25 NDCs
11 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)1819
US makers11 labelers
Packages45
DEA / ScheduleCIII

US acquisition costNADAC · per unit

Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.172$0.343$0.515$0.686Dec 2025Apr 2026Jul 2026
$0.527
Latest avg · Jul 22, 2026
-12%
Since Dec 17, 2025
11
Active US suppliers
62%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

196K393K589K786K2025 Q12025 Q22025 Q32025 Q42026 Q1
605K
Rx · 2026 Q1
18.8M
Units dispensed
-5%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it11 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager23SUPPLYING
Clinical Solutions Wholesale, LLCunknown5SUPPLYING
Golden State Medical Supply, Inc.unknown2SUPPLYING
Major Pharmaceuticalsunknown2SUPPLYING
Unit Dose Solutions, Inc.unknown2SUPPLYING
SpecGx LLCunknown2SUPPLYING
Accord Healthcare Inc.unknown2SUPPLYING
Redpharm Drugunknown2SUPPLYING
REMEDYREPACK INC.repackager2SUPPLYING
Hikma Pharmaceuticals USA Inc.unknown2SUPPLYING
Asclemed USA, Inc.unknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.